Oncimmune Holdings (UK) Probability of Future Stock Price Finishing Under 15.97

ONC Stock   14.75  0.05  0.34%   
Oncimmune Holdings' future price is the expected price of Oncimmune Holdings instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Oncimmune Holdings plc performance during a given time horizon utilizing its historical volatility. Check out Oncimmune Holdings Backtesting, Oncimmune Holdings Valuation, Oncimmune Holdings Correlation, Oncimmune Holdings Hype Analysis, Oncimmune Holdings Volatility, Oncimmune Holdings History as well as Oncimmune Holdings Performance.
  
Please specify Oncimmune Holdings' target price for which you would like Oncimmune Holdings odds to be computed.

Oncimmune Holdings Target Price Odds to finish below 15.97

The tendency of Oncimmune Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under  15.97  after 90 days
 14.75 90 days 15.97 
about 39.26
Based on a normal probability distribution, the odds of Oncimmune Holdings to stay under  15.97  after 90 days from now is about 39.26 (This Oncimmune Holdings plc probability density function shows the probability of Oncimmune Stock to fall within a particular range of prices over 90 days) . Probability of Oncimmune Holdings plc price to stay between its current price of  14.75  and  15.97  at the end of the 90-day period is about 18.19 .
Assuming the 90 days trading horizon Oncimmune Holdings plc has a beta of -0.18. This indicates as returns on the benchmark increase, returns on holding Oncimmune Holdings are expected to decrease at a much lower rate. During a bear market, however, Oncimmune Holdings plc is likely to outperform the market. Additionally Oncimmune Holdings plc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Oncimmune Holdings Price Density   
       Price  

Predictive Modules for Oncimmune Holdings

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oncimmune Holdings plc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
10.2514.7619.27
Details
Intrinsic
Valuation
LowRealHigh
9.4013.9118.42
Details
Naive
Forecast
LowNextHigh
9.7014.2218.73
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-2.7-2.7-2.7
Details

Oncimmune Holdings Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Oncimmune Holdings is not an exception. The market had few large corrections towards the Oncimmune Holdings' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Oncimmune Holdings plc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Oncimmune Holdings within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.15
β
Beta against Dow Jones-0.18
σ
Overall volatility
2.30
Ir
Information ratio -0.06

Oncimmune Holdings Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oncimmune Holdings for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Oncimmune Holdings plc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Oncimmune Holdings generated a negative expected return over the last 90 days
Oncimmune Holdings has high historical volatility and very poor performance
Oncimmune Holdings has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 1.15 M. Net Loss for the year was (6.15 M) with profit before overhead, payroll, taxes, and interest of 1.46 M.
Oncimmune Holdings generates negative cash flow from operations
About 20.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Favourable Signals For Oncimmune Holdings Numerous Insiders Acquired Stock - Yahoo Finance

Oncimmune Holdings Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Oncimmune Stock often depends not only on the future outlook of the current and potential Oncimmune Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oncimmune Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding72.5 M
Cash And Short Term Investments3.2 M

Oncimmune Holdings Technical Analysis

Oncimmune Holdings' future price can be derived by breaking down and analyzing its technical indicators over time. Oncimmune Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Oncimmune Holdings plc. In general, you should focus on analyzing Oncimmune Stock price patterns and their correlations with different microeconomic environments and drivers.

Oncimmune Holdings Predictive Forecast Models

Oncimmune Holdings' time-series forecasting models is one of many Oncimmune Holdings' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Oncimmune Holdings' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Oncimmune Holdings plc

Checking the ongoing alerts about Oncimmune Holdings for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Oncimmune Holdings plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Oncimmune Holdings generated a negative expected return over the last 90 days
Oncimmune Holdings has high historical volatility and very poor performance
Oncimmune Holdings has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 1.15 M. Net Loss for the year was (6.15 M) with profit before overhead, payroll, taxes, and interest of 1.46 M.
Oncimmune Holdings generates negative cash flow from operations
About 20.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Favourable Signals For Oncimmune Holdings Numerous Insiders Acquired Stock - Yahoo Finance

Other Information on Investing in Oncimmune Stock

Oncimmune Holdings financial ratios help investors to determine whether Oncimmune Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncimmune with respect to the benefits of owning Oncimmune Holdings security.